A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study

Harry Buller, Anthonie Lensing, M Prins, G Agnelli, A Cohen, Alexander Gallus, F Misselwitz, G Raskob, Sebastian Schellong, Annelise Segers

    Research output: Contribution to journalArticlepeer-review

    336 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)2242-2247
    Number of pages6
    Issue number6
    Publication statusPublished - 2008

    Cite this